This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Spiriva
  • /
  • Evaluation of Tiotropium 5 �g/Day Delivered Via th...
Clinical trial

Evaluation of Tiotropium 5 �g/Day Delivered Via the Respimat� Inhaler Over 48 Weeks in Patients With Severe Persistent Asthma on Top of Usual Care (Study II)

Read time: 2 mins
Last updated:13th Oct 2008
Source: Clinical Trials
Identifier: NCT00776984
Register for free access to this exclusive healthcare learning resource

Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest